Viracta Therapeutics Inc. Stock
A loss of -2.070% shows a downward development for Viracta Therapeutics Inc..
Our community identified positive and negative aspects for Viracta Therapeutics Inc. stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Viracta Therapeutics Inc. stock. On the other hand our users think that "Unique positioning" could be a problem in the future.
Pros and Cons of Viracta Therapeutics Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Viracta Therapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Viracta Therapeutics Inc. | -2.070% | -4.698% | -33.019% | -32.381% | 43.725% | -88.685% | -98.123% |
| Ardelyx Inc. | -4.380% | -16.636% | 8.504% | 81.259% | 24.498% | 28.500% | - |
| Evolus Inc | - | -3.333% | 4.505% | 26.087% | 28.177% | 57.823% | - |
| Salarius Pharmaceuticals Inc. | -2.360% | 1.471% | 1.471% | -62.703% | -25.405% | -98.319% | -99.992% |